Form 8-K - Current report:
SEC Accession No. 0001193125-26-269493
Filing Date
2026-06-12
Accepted
2026-06-12 16:19:09
Documents
9
Period of Report
2026-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K whwk-20260611.htm   iXBRL 8-K 64691
  Complete submission text file 0001193125-26-269493.txt   171438

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT whwk-20260611.xsd EX-101.SCH 24877
12 EXTRACTED XBRL INSTANCE DOCUMENT whwk-20260611_htm.xml XML 4735
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 261086988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)